<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01109641</url>
  </required_header>
  <id_info>
    <org_study_id>MDT-PINGEP</org_study_id>
    <nct_id>NCT01109641</nct_id>
  </id_info>
  <brief_title>PhrenIc Nerve mappinG and Stimulation EP Catheter Study: PING-EP Study</brief_title>
  <acronym>PING-EP</acronym>
  <official_title>PhrenIc Nerve mappinG and Stimulation EP Catheter Study: PING-EP Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Italia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Italia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PING-EP study is designed to evaluate electrode properties on phrenic nerve stimulation
      (PNS) in coronary sinus using a commercially available diagnostic electrophysiology catheter.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of electrode property on phrenic nerve stimulation (PNS)</measure>
    <time_frame>at implant</time_frame>
    <description>Effect of electrode property on PNS in the cardiac veins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of electrode configuration on phrenic nerve stimulation (PNS)</measure>
    <time_frame>at implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrode polarity effect on phrenic nerve stimulation (PNS)</measure>
    <time_frame>at implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of electrode property on sensing (r-wave amplitude)</measure>
    <time_frame>at implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of phrenic nerve stimulation (PNS) in the cardiac veins</measure>
    <time_frame>at implant</time_frame>
    <description>Incidence of PNS occurrence in different locations in the cardiac vein</description>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>diagnostic electrophysiology catheter</intervention_name>
    <description>electrical measurements through a diagnostic electrophysiology catheter</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is indicated for a cardiac resynchronization therapy-pacemaker or
             defibrillator (CRT-P/CRT-D) implant, for an upgrading from a previously implanted
             single/dual chamber pacemaker/implantable cardioverter (ICD) or for system revision
             requiring repositioning of the transvenous left ventricular (LV) lead

          -  Patient has signed and dated the study-specific Patient Informed Consent form

          -  Subject is at least 18 years of age

        Exclusion Criteria:

          -  Patient has a previous LV lead implanted not requiring repositioning

          -  Pregnant woman

          -  Patient is enrolled or planning to participate in any concurrent study, which would
             confound the results of this trial as determined by Medtronic, during the course of
             this clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Biffi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico S. Orsola Malpighi, Bologna, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Zanon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale S. Maria della Misericordia, Rovigo, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luigi Padeletti</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda ospedaliero-universitaria Careggi, Firenze, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Bertaglia</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Unità Socio Sanitaria di Dolo Mirano, Mirano (VE), Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Unità Socio Sanitaria di Dolo Mirano</name>
      <address>
        <city>Mirano</city>
        <state>Venezia</state>
        <zip>30035</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitana di Bologna, Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Maria della Misericordia</name>
      <address>
        <city>Rovigo</city>
        <zip>45100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007 Jun 13;297(22):2502-14. Review.</citation>
    <PMID>17565085</PMID>
  </reference>
  <reference>
    <citation>Gurevitz O, Nof E, Carasso S, Luria D, Bar-Lev D, Tanami N, Eldar M, Glikson M. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol. 2005 Dec;28(12):1255-9.</citation>
    <PMID>16403156</PMID>
  </reference>
  <reference>
    <citation>Albertsen AE, Nielsen JC, Pedersen AK, Hansen PS, Jensen HK, Mortensen PT. Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications. Pacing Clin Electrophysiol. 2005 Jun;28(6):483-8.</citation>
    <PMID>15955178</PMID>
  </reference>
  <reference>
    <citation>Alonso C, Leclercq C, d'Allonnes FR, Pavin D, Victor F, Mabo P, Daubert JC. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart. 2001 Oct;86(4):405-10.</citation>
    <PMID>11559679</PMID>
  </reference>
  <reference>
    <citation>Knight BP, Desai A, Coman J, Faddis M, Yong P. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol. 2004 Jul 7;44(1):72-7.</citation>
    <PMID>15234410</PMID>
  </reference>
  <reference>
    <citation>Ellery S, Paul V, Prenner G, Tscheliessnigg K, Merkely B, Malinowski K, Fröhlig G, Hintringer F, Bosse O, Diotallevi P, Ravazzi AP, Flathmann H, Danilovic D, Unterberg-Buchwald C; OVID Study Investigators. A new endocardial &quot;over-the-wire&quot; or stylet-driven left ventricular lead: first clinical experience. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S31-5.</citation>
    <PMID>15683519</PMID>
  </reference>
  <reference>
    <citation>Matsumoto Y, Krishnan S, Fowler SJ, Saremi F, Kondo T, Ahsan C, Narula J, Gurudevan S. Detection of phrenic nerves and their relation to cardiac anatomy using 64-slice multidetector computed tomography. Am J Cardiol. 2007 Jul 1;100(1):133-7. Epub 2007 May 21.</citation>
    <PMID>17599455</PMID>
  </reference>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2010</study_first_submitted>
  <study_first_submitted_qc>April 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2010</study_first_posted>
  <last_update_submitted>October 6, 2010</last_update_submitted>
  <last_update_submitted_qc>October 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Francesco De Seta</name_title>
    <organization>Medtronic Italia</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

